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Abstract:  
The F420-dependent NADP oxidoreductase enzyme from Methanobrevibacter smithii catalyzes the important electron transfer step during methanogenesis. 
Therefore, it may act as potential target for blocking the process of methane formation. Its protein sequence is available in GenBank (accession number: 
ABQ86254.1) however no report has been found about its 3D protein structure. In this work, we first time claim 3D model structure of F420-dependent NADP 
oxidoreductase enzyme from Methanobrevibacter smithii by comparative homology modeling method. Swiss model and ESyPred3d (via Modeller 6v2) software’s 
were generated the 3D model by detecting 1JAX (A) as template along with sequence identities of 34.272% and 35.40%. Furthermore, PROCHECK with 
Ramachandran plot and ProSA analysis revealed that swiss model produced better model than Modeller6v2 with 98.90% of residues in favored and additional 
allowed regions (RM plot) as well as with ProSA Z score of -7.26. In addition, we investigated that the substrate F420 bound at the cavity of the model. 
Subsequently, inhibitor prediction study revealed that Lovastatin (-22.07 Kcal/mol) and Compactin (Mevastatin) (-21.91 Kcal/mol) produced more affinity for 
model structure of NADP oxidoreducatse as compared to F420 (-14.40 Kcal/mol). It indicates that the Lovastatin and Compactin (Mevastatin) compounds 
(Negative regulator) may act as potential inhibitor of F420 dependent NADP oxidoreducatse protein. 
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Background: 
The decomposition of organic compounds in the absence of oxygen produces 
methane as a main product [1]. Likewise, the anaerobic bacteria are mostly 
performing the function of decomposition in the absence of oxygen known as 
anaerobic microbial decomposition. Most of the methane producing bacteria 
belongs to the domain archaea [1]. They further extended to the kingdom 
Euryarchaeota. These methane producing bacteria i.e methanogens are 
classified in to five orders i.e Methanopyrales, Methanococcales, 
Methanobacteriales, Methanosarcinales and Methanomicrobiales [2, 3]. Apart 
from these, Methanobrevibacte phlotypes are the most dominant phylotype of 
methanogens present in Australia, Canada and European countries. These 
bacteria’s used different substrates for completing their energy requirement and 
produce methane. The well known substrates for methanogenic bacteria are 
carbon dioxide, hydrogen, acetate and methanol etc [1]. But this increasing 
level of methane in the environment is a matter of global concern. Everyday 
scientists are making experiments in order to reduce methane by mitigating 
methanogens. A major portion of the methane in the environment is coming 
from the livestock sector so it is worthwhile to stress majorly on the strategies 
or methods that will mitigate the methane emission from rumen [4, 5].  
Methane producing pathway in methanogens that utilize carbon dioxide and 
molecular hydrogen involves ten methanogen specific enzymes which catalyze 
unique reactions using unique coenzymes [1, 4, 6, 7].  
     
One of them is F420 H2: NADP oxidoreductase (Fno) that catalyzes the 
electron transfer step between NADP+ and F420 [8]. During the reaction, 
NADP isreduced to NADPH by accepting one or more hydrides (H−) from 
F420  [9]. It is an  important step for regulation of methane formation in 
methanogen bacterium such asMethanobrevibacter smithii (ATCC 35061). 
Therefore, the NADP oxidoreductase enzyme may play vital role in the 
formation of methane in Methanobrevibacter smithii. This group of 
methanogens also finds in human gut and helps in the digestion of 
polysaccharides which affects harvesting of host calorie [10]. It also dominants 
the 10% of anaerobes in the human gut. Methanobrevibacter smithii uses large 
carbohydrates as sole carbon source and degrades them to methane which is 
toxic to body. Furthermore, the excreta with high methane content is consumed 
by bacterium in order to release free methane which is a major issue for BIOINFORMATION  open access 
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environmental safety. Therefore, there is need to block the synthesis of 
methane in Methanobrevibacter smithii to reduce its toxicity in the 
environment. The synthesis of methane can be hindered by decreasing the 
activity of NADP oxidoreductase enzyme in Methanobrevibacter smithii. 
However, the 3D protein structure of NADP oxidoreductase enzyme from 
Methanobrevibacter smithii is still unknown. Therefore, in the proposed work 
we developed 3D model structure of F420- dependent NADP oxidoreductase 
protein from Methanobrevibacter smithii whose protein sequence is available 
in genebank (Accession number: ABQ86254.1). We explored comparative 
homology modeling method for 3D model development. In addition, we 
determined the putative functional site for the model protein via various 
prediction servers which was further validated by molecular docking approach. 
Moreover, several works have been already reported for direct or indirect 
inhibition of methane production [11-15]. Therefore, in our research work we 
determined putative inhibitor of F420 dependent NADP oxidoreductase protein 
to inhibit the methane producing pathway in Methanobrevibacter smithii. 
 
Methodology: 
The protein sequence of F420-dependent NADP oxidoreductase enzyme from 
Methanobrevibacter smithii was obtained from gene bank (Accession number: 
ABQ86254.1) and furnished as query sequence for homology modeling. 
   
Homology modeling: 
The protein sequence was subjected for comparative homology modeling via 
Swiss model [16] and ESyPred3D (via Modeller 6v2) software’s [17] to 
generate putative 3D model. The Swiss model performs the sequence 
alignments and searches the putative template protein for generating the 3D 
model for query sequence. The ESyPred3D has been incorporated with 
Modeller (version 6v2) program for generating the putative 3D model. All the 
modeling parameters were set to be default.  The model structure was further 
verified by PROCHECK and PROSA analysis. 
 
Energy minimization by GROMOS96: 
The model structure was further optimized by energy minimization via 
GROMOS96, implemented in Swiss pdb viewer software. GROMOS96 
performs the molecular dynamics of all the bonded and non bonded atoms with 
in the model structure and obtain the minimum potential energy. 
 
Functional site prediction: 
  We subjected the model structure to different function and functional site 
prediction servers e.g. DALI, BLAST, PSI-BLAST, PROFUNC, Q-SITE 
FINDER and PROSITE. The BLAST and PSI-BLAST were used for function 
verification. On the other hand, the PROFUNC and Q-SITE FINDER were 
used for structure based functional site prediction.   
 
Substrate verification: 
We determined the putative substrate for the query protein (modeled protein) 
via Molecular docking. Here, we used the Patch dock [18]  and Autodock 
(version 4) [19] software’s for performing molecular docking. We extracted the 
substrate molecules files from the template protein pdb file (obtained from 
homology modeling approach) and converted into 3D structure via CORINA 
server (http://www.molecular-networks.com/online_demos/corina_demo). The 
substrates were docked against the model structure via mentioned docking 
software’s. We further divided the docking approach in two steps (1) Blind 
docking (2) Refined docking. In the blind docking via Patchdock, we 
considered the whole modeled protein structure as docking target. On the other 
hand, in refined docking approach via Autodock4, we generated the grid map 
around the selective active site residues (obtained from fuctional site prediction 
servers and from blind docking approach) with grid point spacing of 0.375 A
0( 
Figure 1).  All docking parameters were set to be default.Subsequently, the 
substrates were ranked based on docking score obtained after Patchdock. On 
the other hand, in Autodock4.0, a log file has been generated (dlg) from where 
we calculated docking energy which is the sum of Intermolecular energy and 
internal energy .We selected the  most stable confirmations of the substrate  
based on  lowest docking energy and  their binding mode was analyzed at  
resulting selected functional site.  
 
Inhibitor prediction: 
Finally, the inhibitor compounds were detected for modeled F420-dependent 
NADP oxidoreductase protein in order to decrease its catalytic activity. We 
obtained reported inhibitor compounds for methanogenic bacteria from 
literature. Their SMILES strings were obtained from Pubchem database and 3D 
structures were generated by CORINA server.  The compounds were docked 
against the modeled structure of F420-dependent NADP oxidoreductase. 
 
 
Figure 1: Schematic of the Methodology: (1) The protein sequence of F420-
dependent NADP oxidoreductase enzyme from Methanobrevibacter smithii 
was obtained from gene bank database, (2) The query sequence was subjected 
to homology modeling via Swiss model and ESyPred3d (Modeller6v2) 
software’s, (3) The 3D model structure was obtained, (4) The quality of 3D 
model was further verified by PROCHECK and PROSA analysis, (5) The 
selective 3D model was further furnished for energy minimization by 
GROMOS96, (6) Next, the optimized model was subjected for functional site 
prediction by PINTS, PROFUNC and Q-SITE FINDER servers, (7) In 
addition, the substrate prediction was performed for modeled NADP 
oxidoreductase enzyme, (8) Subsequently, the potential inhibitor compounds 
were predicted for the model protein of NADP oxidoreductase enzyme. 
Furthermore, the binding site residues were extracted from model protein. The 
analysis was divided in three steps (9a) The putative functional site residues 
were extracted from servers, (9b) The substrate and (9c) inhibitors binding 
cavity was determined after docking, (10) The binding site residues were 
enumerated which surrounded (10a) substrate and (10b) inhibitor (as center) 
with 6Ǻ of radius and (11) The extracted residues from steps 10a, and 10b were 
compared with the residues from functional site prediction servers. 
 
 
Figure 2: Modeled structure of F420-dependent NADP oxidoreductase protein 
(Gene bank accession number: ABQ86254.1) BIOINFORMATION  open access 
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Results: 
Molecular Modeling: 
We are interested in uncovering structure, substrate and inhibitor of 
F420dependent NADP oxidoreductase (target) from Methanobrevibacter 
smithii.  The Swiss model software generated the 3D model structure of query 
protein F420dependent NADP oxidoreductase at resolution of 1.8 Ǻ based on 
template protein 1JAX (chain A) with sequence identity of 34.272% and e-
value of 2.40e-26 (Figure 2). On the other hand, the EsyPred3D (via Modeller 
(version 6v2)) developed model structure based on same template protein 
1JAX (chain A) with sequence identity of 35.40% (using ALIGN program). 
The Ramachandran plot analysis (by PROCHECK) of the model structure from 
ESyPred3D is showed that 97.30% of the residues are in favored and additional 
allowed regions. However structure from Swiss model is showed 98.90% 
residues are in favored and additional allowed regions .Quality assessment of 
the model via ProSA revealed that the models from both EsyPred3D and Swiss 
model matched with NMR region of the plot with Z score of -7.25 and -7.26 
(Figure 3). ProSA analysis indicated that the model structure of NADP 
oxidoreductase obtained match with the known proteins whose structures have 
been already determined by NMR experiments. It signifies good quality of our 
model. Furthermore, we considered Swiss model structure for our further study 
(Figure 2). The measurement of bad non-bonded interaction for Swiss model 
structure showed that at 2.0  Ǻ of resolution, the number of bad contacts is of 
five residues per 100 residues. In addition, Secondary structure prediction of 
F420dependent NADP oxidoreductase revealed that the modeled structure 
consist of Helix-Strand-Coil like structure. Energy minimization was 
performed by GROMOS96 which optimized the model structure from initial 
energy -4019.835 KJ/mol to final energy of -5671.013 KJ/mol. 
 
 
Figure 3: ProSA analysis of Modeled protein structure of F420-dependent 
NADP oxidoreductase protein via (A) Swiss model (B) ESyPred3d. It 
represents that the model structures from both the software’s are matching well 
with the known proteins whose structures have been determined by NMR 
experiments. 
 
Functional site residues: 
Functional site prediction by state of art methods such as DALI, PINTS, 
Profunc and Q Site Finder enumerated the putative active site residues in the 
model structure (Figure 1). DALI server produced close match with 1JAX 
(chain A) (Z score 37.4, RMSD 0.7) and 1JAY (chain A) (Z score 34.9, RMSD 
0.9). These are known oxidoreductase enzymes with structures in RCSB data 
bank and were also detected during homology modeling of query protein. 
These servers detected the following putative functional site residues in the 
target protein: GLY7, GLY 8, THR 9, GLY 10, PRO 11, GLN 12, GLY 10 13, 
LEU 14, SER31, ARG32, LYS36, LEU 73, THR 74, VAL75, PRO 76, LEU 
77, GLN 80, ALA 99, THR 100, VAL101, ASN 142, ASN 146, THR 201. The 
ligand molecules F420 and NADP were separated from pdb file of 1JAY. Note 
that no ligand has been reported for 1JAX.We download their SMILES strings 
from Pubchem and converted into 3D structures by CORINA server and saved 
in pdb file format (Figure 4). The docking of the ligands against modeled 
oxidoreductase protein produced higher docking score for F420 (score 6150) as 
compared to NADP (score 4195). The ligand F420 binds at the cavity of 
oxidoreductase protein. We took docked F420 ligand as a centre and at 6 Ǻ of 
radius to select the surrounding residue environment. The following active site 
residues surround the ligand F420: GLY7, GLY8, THR9, PRO11, GLN12, 
GLY13, ILE16, ILE72, LEU73, THR74, VAL75, PRO76, LEU77, GLN78, 
ALA79, GLN80, LEU97, ASP98, ALA99, THR100, VAL101, PRO102, 
LEU103 ,GLU104, THR105 ,PRO114, LEU115, ILE117, ALA122, ALA140 
,PHE141, ASN142, ASN143, ILE144 ,SER145, ASN146, SER147, HIS148, 
LEU149 ,ASP154, ILE156, CYS158, ILE197, GLU198, SER199, ILE200 
,THR201, PRO202, LEU203, LEU204, ILE205, GLY206, MET207, ASN208, 
ILE209, LYS210, PHE211 and LYS212. These residues are in agreement with 
the functional site residues predicted by different function site prediction 
servers. Furthermore, refined docking by Autodock4 for selective functional 
site (obtained by blind docking approach and predicted by servers) produced 
lower docking energy of - 14.40 Kcal/mol for F420 (Figure 5). 
 
 
Figure 4: Structure of Compactin (Mevastatin), Lovastatin and F420. 
 
 
Figure 5: The F420 (pink) binds at the cavity of modeled structure (green) of 
F420- dependent NADP oxidoreductase protein and residues surrounding the 
F420 ligand at 6A0 radius. The residues GLN12, LEU77, ALA99 and VAL101 
make hydrogen bonds with F420. BIOINFORMATION  open access 
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Figure 6: The figure showed (A) Lovastatin inhibitor (pink) binds at the cavity of modeled structure (green) of F420-dependent NADP oxidoreductase protein and 
residues surrounding the Lovastatin ligand at 6A0 radius. The residues GLY10, GLY13 THR74 and ILE144 make hydrogen bonds (blue) with Lovastatin. (B) 
Compactin (Mevastatin) inhibitor (pink) binds at the cavity of modeled structure (green) of F420-dependent NADP oxidoreductase protein and residues 
surrounding the Compactin (Mevastatin) ligand at 6A0 radius. The residues GLN12, GLY13, THR74 and ILE144 make hydrogen 
bonds (blue) with Compactin. 
 
Docking with inhibitors: 
Docking via Patchdock produced higher docking score for Lovastatin (score 
4852) and Compactin (Mevastatin) (score 4778) along with oxidoreductase 
natural ligand F420 (score 6150) (Figure 4). Refined docking (making grid 
map on previously predicted active site) also produced lower docking energy 
for Lovastatin -22.07 Kcal/mol and Compactin (Mevastatin) -21.91 Kcal/mol 
which is much lower then oxidoreducatse natural ligand F420, -14.40 Kcal/mol 
(Figure 5 & 6). Both the inhibitors bind at the cavity of modeled F420 
dependent NADP oxidoreducatse protein and show higher affinity as compared 
to F420 (Figure 5 & 6). Our research establishes that Lovastatin and 
Compactin (Mevastatin) may act as potent inhibitor for F420 dependent NADP 
oxidoreducatse protein in order to block its active site.Based on the matches, 
we propose the following putative functional role of the target: The target may 
participate in hydride transfer of DNA photolyase reaction. The N terminal of 
the protein may have dinucleotide binding Rossmann fold domain. The target 
may be a homodimer catalyzing the reversible reduction of NADP+ by the help 
of F420H2. It may have NADP binding site at N terminal domain and F420 
binding at the C terminal domain. 
 
Discussion: 
In our study, we determine the 3D model structure of the F420-dependent 
NADP oxidoreductase from Methanobrevibacter smithii. We investigate that 
Swiss model software develop more accurate protein model for our query 
sequence as compare to ESyPred3D. It also verifies by PROCHECK and 
ProSA analysis. These methods confirm the accuracy of our protein model. 
Structure based functional site prediction methods enumerate the putative 
amino acid residues from our protein model of F420- dependent NADP 
oxidoreductase enzyme. We detect that these residues are making ligand 
binding site pocket. Therefore, in extension of our study, we determine the 
substrate and inhibitor for our model protein via docking. We find that ligand 
F420 binds at protein cavity. Results from functional site prediction and 
residues selection from docking experiment are complementary to each other. 
In addition, the inhibitor compounds Lovastatin (-22.07 Kcal/mol) and 
Compactin (Mevastatin) (-21.91 Kcal/mol) show more affinity for model 
protein as compare to natural ligand F420 (-14.40 Kcal/mol). They share the 
same cavity as by F420 and surround by similar residues. The Lovastatin is a 
fungal metabolite isolated from cultures of Aspergillus terreus and Compactin 
(Mevastatin) is an antifungal metabolite from Penicillium brevicopactum. Our 
research establishes that Lovastatin and Compactin (Mevastatin) may act as 
potent inhibitor for F420 dependent NADP oxidoreducatse protein in order to 
block its active site. 
 
Conclusion: 
The sequence and functional site prediction servers confirmed that the query 
sequence is putative F420-dependent NADP oxidoreductase protein. Model 
development and functional site prediction of F420-dependent NADP 
oxidoreductase protein will give greater insight in understanding the role of 
amino acids for catalyzing the reaction mechanism. Docking experiments 
detected putative inhibitor of F420-dependent NADP oxidoreductase protein 
which may help in blocking the methane production function of protein. As the 
production of methane in excess amount is harmful for the environment 
therefore blocking the active site by Lovastatin and Compactin (Mevastatin) 
inhibitors render the enzyme unable to bind with the substrate which results in 
decreased methane production and reduction in environment pollution. Our 
prediction may help the biologist to design putative inhibitor against F420-
dependent NADP oxidoreductase protein for regulating its active related to 
global environment concern. 
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